Dario Crosetto, an Italian-American scientist, is challenging the scientific establishment to embrace transparency and accountability in the funding and development of his 3D-CBS (3D Complete Body Screening) technology. This advanced PET/CT imaging system, derived from his earlier 3D-Flow invention in particle physics, promises to halve premature cancer mortality and reduce healthcare costs through early detection. Despite the potential benefits, Crosetto claims his innovations have been overlooked in favor of less efficient, more costly alternatives, leading to a call for a public, face-to-face scientific review to compare technologies.
Crosetto's 3D-Flow technology, recognized as a breakthrough in 1993, offers a solution to the inefficiencies in current Level-1 Trigger systems used at CERN, which he argues waste billions in taxpayer funds. His proposal for a more efficient system has been documented in peer-reviewed articles and presentations, yet funding has consistently been directed towards FPGA-based systems that have repeatedly failed. The implications of this funding disparity extend beyond particle physics, with Crosetto's 3D-CBS technology offering transformative potential for early cancer detection and treatment.
The call for transparency is not just about correcting past funding decisions but ensuring future investments in scientific research serve the public good. Crosetto's efforts to organize a public scientific meeting aim to bring his evidence-based solutions to light, challenging the status quo and advocating for a shift towards more effective, cost-efficient technologies in both physics and healthcare. The outcome of this call could have far-reaching implications for scientific research funding, cancer treatment, and the integrity of the scientific process itself.
